Products Affected - Description
Hydroxyzine injection, American Regent
25 mg/mL, 1 mL vial (NDC 00517-4201-25)
50 mg/mL, 1 mL vial (NDC 00517-5601-25)
50 mg/mL, 2 mL vial (NDC 00517-5602-25)
50 mg/mL, 10 mL multiple-dose vial (NDC 00517-5610-25)
Reason for the Shortage
- American Regent has hydroxyzine injection on shortage due to manufacturing delays.
- American Regent is the sole supplier of hydroxyzine injection.
No presentations are available.
Estimated Resupply Dates
American Regent has hydroxyzine 25 mg/mL 1 mL vials and hydroxyzine 50 mg/mL 1 mL, 2 mL, and 10 mL vials on back order and the company estimates a release date of January 2015.
October 21, 2014; August 8, 2014; May 6, 2014; February 10, 2014; November 12, 2013; September 9, 2013; July 12, 2013; June 18, 2013; May 30, 2013; April 24, 2013; March 27, 2013; February 21, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins